Voloridge Investment Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.98M Sell
789,506
-270,649
-26% -$1.36M 0.01% 810
2025
Q1
$6.87M Buy
1,060,155
+290,430
+38% +$1.88M 0.03% 691
2024
Q4
$5.65M Sell
769,725
-205,575
-21% -$1.51M 0.02% 745
2024
Q3
$7.3M Sell
975,300
-249,598
-20% -$1.87M 0.03% 680
2024
Q2
$10.9M Buy
1,224,898
+521,370
+74% +$4.64M 0.04% 543
2024
Q1
$7.13M Buy
703,528
+149,722
+27% +$1.52M 0.03% 566
2023
Q4
$5.57M Buy
553,806
+113,038
+26% +$1.14M 0.02% 593
2023
Q3
$4.13M Buy
+440,768
New +$4.13M 0.02% 716
2022
Q1
Sell
-355,091
Closed -$14.9M 1721
2021
Q4
$14.9M Buy
355,091
+153,578
+76% +$6.43M 0.08% 350
2021
Q3
$8.77M Sell
201,513
-6,656
-3% -$290K 0.06% 475
2021
Q2
$9.84M Sell
208,169
-75,600
-27% -$3.57M 0.07% 416
2021
Q1
$14.5M Sell
283,769
-67,356
-19% -$3.45M 0.11% 259
2020
Q4
$9.4M Buy
+351,125
New +$9.4M 0.08% 283